Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT).
- Disclosed ownership: 2.7%.
- Date of event: 31 Dec 2025.
MILLENNIUM MANAGEMENT LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- PHAT
- Shares outstanding
- 77,117,778 shares
- Disclosed Ownership
- 2,082,180 shares
- Ownership
- 2.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 27 Jan 2026, 16:25:05 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 03 Nov 2025
- Next filing
- 12 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 2.7% ownership in Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 03 Nov 2025.
- Current filing was accepted on 27 Jan 2026, 16:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 1.6% | 1,255,161 | 0 | 1,255,161 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 2.7% | 2,082,180 | 0 | 2,082,180 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 2.7% | 2,082,180 | 0 | 2,082,180 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 2.7% | 2,082,180 | 0 | 2,082,180 | /s/ Israel A. Englander | Israel A. Englander |